Moving Platform Posturography – often referred to as Computerized Dynamic Posturography (CDP) – is a specialized diagnostic tool used to evaluate balance disorders and dizziness. For patients suffering from chronic vertigo, falls, or unexplained disequilibrium, this test provides objective data on sensory organization and motor coordination. However, a critical barrier remains: insurance coverage. This article explores the landscape of reimbursement for CDP under private insurance, Medicare, and the legal considerations that providers and patients must navigate.
Understanding Moving Platform Posturography (CDP)
Computerized Dynamic Posturography uses a moving force plate and/or visual surround to systematically assess a patient’s ability to maintain balance under various sensory conditions. Unlike standard clinical tests (e.g., Romberg or caloric testing), CDP isolates deficits in the vestibular, visual, and somatosensory systems. This objective data is invaluable for confirming a diagnosis of central or peripheral vestibular dysfunction, quantifying fall risk, and guiding rehabilitation.
Because of its specialized nature, CDP is often performed in balance centers, ENT clinics, and neurology practices. The equipment is costly, and the test requires trained personnel. As a result, reimbursement from insurers is not always guaranteed – making insurance verification a crucial step before testing.
Medicare Coverage for CDP
Medicare provides specific coverage for Moving Platform Posturography under certain conditions. The Centers for Medicare & Medicaid Services (CMS) consider CDP (CPT codes 92548 and 92549) to be a diagnostic test for balance disorders. However, coverage is not automatic. Medicare Part B may cover the test when:
- The patient has a documented complaint of dizziness, imbalance, or recurrent falls.
- The referring provider has performed a clinical history and physical exam.
- Other non-invasive diagnostic tests (e.g., videonystagmography or rotary chair) have been inconclusive or are contraindicated.
- The test is ordered to differentiate between central and peripheral vestibular disorders or to evaluate postural stability.
Importantly, Medicare does not cover CDP for screening asymptomatic individuals or for routine fall risk assessment alone. Providers must ensure that medical necessity is clearly documented. If Medicare denies the claim, the patient may be liable, but under legal rules, the provider must issue an Advance Beneficiary Notice (ABN) before testing to shift financial responsibility.
Reimbursement rates vary by region, but typically Medicare pays a fraction of the billed amount. For example, the national average allowed amount for CPT 92548 is approximately $150–$250, which may not cover the full cost of the equipment and staff time. Many private insurers follow Medicare’s lead on coverage criteria.
Private Insurance & CDP Coverage
Private insurance plans – including PPOs, HMOs, and employer-sponsored plans – often require prior authorization for Moving Platform Posturography. Coverage policies vary widely. Some insurers consider CDP experimental or investigational, especially for indications like “falls prevention” without a vestibular diagnosis. Others recognize it as a medically necessary standard.
To improve reimbursement odds, providers should:
- Obtain pre-authorization with detailed clinical notes supporting dizziness or balance impairment.
- Use correct ICD-10 codes, such as R42 (dizziness and giddiness), H81.0 (Meniere’s disease), or H81.2 (vestibular neuronitis).
- Provide evidence that prior simpler tests (e.g., positional testing or audiometry) were normal or equivocal.
- Appeal denials with peer-to-peer reviews, citing published medical literature and CMS guidelines.
For patients, it is essential to call their insurance company and ask whether “computerized dynamic posturography” or “moving platform posturography” is a covered benefit under their specific plan. Some plans exclude “balance testing” unless it is performed in conjunction with physical therapy.
Legal Considerations & Patient Protection
The legal landscape surrounding CDP coverage involves several key issues. First, under the Health Insurance Portability and Accountability Act (HIPAA), patients have a right to receive a written explanation of benefits (EOB) and to request coverage decisions. If an insurer denies coverage, the patient can file an internal appeal and, if necessary, an external review.
Second, legal liability may arise if a provider fails to disclose potential out-of-pocket costs. If a test is not covered by Medicare or private insurance and the patient is not informed in advance, the provider may be unable to collect payment. This is especially relevant for Medicare patients who have not signed an ABN.
Third, in personal injury or workers’ compensation cases, legal teams often use CDP results as objective evidence of balance impairment. In this context, insurance coverage may be determined by the third-party payer (e.g., auto insurance or workers’ comp carrier). The standards for medical necessity are often broader in litigation, but providers must still submit proper documentation.
Finally, state-specific regulations may affect coverage. For example, some states have laws requiring insurers to cover diagnostic testing for balance disorders if the patient meets certain criteria. Patients and providers should consult with a healthcare attorney or ombudsman if coverage disputes arise.
Practical Tips for Providers & Patients
Whether you are a clinician ordering a CDP or a patient seeking clarity on coverage, here are actionable steps:
- For Providers: Always verify benefits and obtain written pre-authorization. Use the terminology “Computerized Dynamic Posturography (CDP)” on billing forms. Keep a copy of the referring physician’s note that clearly states “dizziness” or “imbalance” as the reason for the test.
- For Patients: Ask your doctor’s office to check if your insurance plan covers “Moving Platform Posturography” under your medical or diagnostic benefit. If Medicare is your primary insurance, confirm that the provider will accept Medicare assignment and whether an ABN is required.
- For Legal Professionals: Request the complete test report (including the sensory organization test scores) to support claims of disability or impairment. Be aware that insurers may argue that CDP is not “standard of care” – medical literature confirms it is widely accepted for complex dizziness cases.
In summary, while Moving Platform Posturography (CDP) is a powerful tool for diagnosing dizziness, insurance coverage – including Medicare – requires careful navigation of medical necessity rules, prior authorization, and legal protections. By understanding the coverage landscape and documenting thoroughly, providers can help patients access this valuable test while minimizing financial risk. For patients, being proactive about insurance verification is the first step toward a clearer diagnosis and a steadier future.